Actualizar mis citas con la selección
Presentar
resultados
Nadkarni GN, Lala A, Bagiella E, Chang HE, Moreno P, Pujadas E, Arvind V, Bose S, Charney AW, Chen MD, Cordon-Cardo C, Dunn AS, Farkouh ME, Glicksberg B, Kia A, Kohli-Seth R, Levin MA, Timsina P, et al..
Anticoagulation, mortality, bleeding and pathology among patients hospitalized with COVID-19: a single health system study.
J Am Coll Cardiol 2020;76:26 de agosto. [Ref.ID 103709]
Hill K, Sucha E, Rhodes E, Carrier M, Garg AX, Harel Z, Hundemer GL, Clark EG, Knoll G, McArthur E, Sood MM.
Risk of hospitalization with hemorrhage among older adults taking clarithromycin vs azithromycin and direct oral anticoagulants.
JAMA Intern Med 2020;180:agosto. [Ref.ID 103655]
Wang Y, Zhang D, Du G, Du R, Zhao J, Jin Y, Fu S, Gao L, Cheng Z, Lu Q, Hu Y, Luo G, et al..
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial.
Lancet 2020;395:29 de abril. [Ref.ID 103630]
Reynolds HR, Adhikari S, Pulgarin C, Troxel AB, Iturrate E, Johnson SB, Hausvater A, Newman JD, Berger JS, Bangalore S, Katz SD, Fishman GI, et al..
Renin–angiotensin–aldosterone system inhibitors and risk of covid-19.
N Engl J Med 2020;382:18 de junio. [Ref.ID 103604]
Dalgaard F, Mulder H, Wojdyla DM, Lopes RD, Held C, Alexander JH, De Caterina R, Washam JB, Hylek EM, Garcia DA, Gersh BJ, Wallentin L, Granger CB, Al-Khatib SM.
Patients with atrial fibrillation taking nonsteroidal anti-inflammatory drugs and oral anticoagulants in the ARISTOTLE trial .
Circulation 2020;141:enero. [Ref.ID 103503]
Actualizar mis citas con la selección